Blog
RSS FeedPosted by Michael Wonder on 11 Oct 2019
ICER releases updated draft evidence report on rheumatoid arthritis therapies
11 October 2019 - Public comment period extended through 8 November 2019; public meeting now to take place on 9 December ...
Posted by Michael Wonder on 09 Oct 2019
High health care costs suggest review is needed: report
8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...
Posted by Michael Wonder on 26 Sep 2019
ICER releases draft evidence report on rheumatoid arthritis therapies
26 September 2019 - Public comment period now open until 24 October 2019; requests to make oral comment during public ...
Posted by Michael Wonder on 12 Sep 2019
ICER publishes evidence report on additive cardiovascular disease therapies
12 September 2019 - Pricing of rivaroxaban and icosapent ethyl aligns well with treatments’ benefits for patients; expert roundtable will discuss ...
Posted by Michael Wonder on 11 Sep 2019
ICER releases draft evidence report on diabetes therapies
11 September 2019 - Public comment period now open until 8 October 2019; Requests to make oral comment during public meeting ...
Posted by Michael Wonder on 03 Sep 2019
Bad diagnosis: health care system muddled, lacking leadership major report finds
3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...
Posted by Michael Wonder on 29 Aug 2019
Academics and consumer groups protest FDA plan to summarise review documents
29 August 2019 - A Food and Drug Administration proposal to substitute detailed reviews of new drugs written by specific ...
Posted by Michael Wonder on 28 Aug 2019
Australian Public Assessment Reports for prescription medicines
28 August 2019 - TGA is reviewing the operation of transparency measures and are considering activities to increase transparency of ...
Posted by Michael Wonder on 19 Aug 2019
Extension to feedback for public consultation - standardised redactions of PBAC Public Summary Documents
19 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers and ...
Posted by Michael Wonder on 24 Jul 2019
ICER releases draft evidence report on additive cardiovascular disease therapies
24 July 2019 - Public comment period now open until 20 August 2019; requests to make oral comment during public ...
Posted by Michael Wonder on 22 Jul 2019
PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting
19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are ...
Posted by Michael Wonder on 05 Jul 2019
PBAC Public Summary Documents - March 2019 meeting
5 July 2019 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2019 PBAC ...
Posted by Michael Wonder on 29 May 2019
Prices of Canadian generic medicines below international average
29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...
Posted by Michael Wonder on 22 May 2019
Asthma Stakeholder Meeting December 2018 – outcome statement
22 May 2019 - The outcome statement for the severe asthma stakeholder meeting held on 14 December 2018 is now available. ...
Posted by Michael Wonder on 14 Apr 2019
PD-L(1) checkpoint inhibitor stakeholder meeting outcome statement
12 April 2019 - The outcome statement for the PD-(L)1 checkpoint inhibitor stakeholder meeting held on 8 February 2019 , ...